# |
PMID |
Sentence |
1 |
15832293
|
They strongly activate DC and monocytes, leading to TNF-alpha and IFN-alpha secretion.
|
2 |
15832293
|
The detailed analysis of the activated cell types, the study of the cytokines released from PBMC cultured with protamine-RNA complexes and recently published results suggest that TLR-7 and TLR-8 may be involved in the recognition of protamine-stabilized RNA.
|
3 |
16081189
|
These include imidazoquinoline compounds such as Imiquimod and Resiquimod (R-848) that bind to TLR7 and 8, as well as CpG oligodeoxynucleotides (CpG ODN) that bind to TLR9.
|
4 |
16423537
|
Importantly, this TLR pathway does not depend on interaction with dendritic cells, but operates independently in Treg cells, relying on TLR8 (with MyD88 as its sole receptor-proximal adaptor) to transduce signals generated by TLR8 ligands.
|
5 |
16461338
|
Specifically, YF-17D activates multiple DC subsets via TLRs 2, 7, 8, and 9 to elicit the proinflammatory cytokines interleukin (IL)-12p40, IL-6, and interferon-alpha.
|
6 |
16461338
|
Furthermore, distinct TLRs appear to differentially control the Th1/Th2 balance; thus, whilst MyD88-deficient mice show a profound impairment of Th1 cytokines, TLR2-deficient mice show greatly enhanced Th1 and Tc1 responses to YF-17D.
|
7 |
16636134
|
NHP were immunized with HIV Gag protein emulsified in Montanide ISA 51, an oil-based adjuvant, with or without a TLR7/8 agonist, a TLR8 agonist, or the TLR9 ligand cytosine phosphate guanosine oligodeoxynucleotides (CpG ODN), and boosted 12 wk later with a replication-defective adenovirus-expressing HIV-Gag (rAD-Gag).
|
8 |
16829609
|
The 3' CCACCA sequence of tRNAAla(UGC) is the motif that is important in inducing Th1-like immune response, and this motif can be recognized by Toll-like receptor 3.
|
9 |
16829609
|
Moreover, the recognitions of different tRNA(Ala)(UGC) fragments by TLR3, TLR7, TLR8, and TLR9 were analyzed.
|
10 |
17476348
|
Synthetic agonists for several TLRs, including TLR3, TLR4, TLR7, TLR8, and TLR9, have been or are being developed for the treatment of cancer.
|
11 |
17576158
|
Higher doses of lentivirus, however, resulted in upregulation of adhesion, costimulatory, and HLA molecules, as well as in increased allostimulatory capacity and secretion of interleukin (IL)-6, IL-8, and tumor necrosis factor-alpha.
|
12 |
17576158
|
Production of IL-12 p70, IL-10, and interferon-alpha was observed only at extremely high doses.
|
13 |
17576158
|
A Toll-like receptor (TLR)-driven luciferase reporter assay showed dose-dependent activation of TLR2, TLR3, and TLR8, which was independent of the pseudotype, production, or transduction protocol and was abrogated on heat inactivation.
|
14 |
17961769
|
Single TLR ligands induced maturation only in adult DC; neonatal DC matured with combined targeting of TLR3/TLR8 or TLR4/TLR8, based on the expression of maturation markers.
|
15 |
17961769
|
Moreover, this interferon-gamma secretion was blocked by anti-IL-12p70 antibodies and increased after addition of recombined IL-12.
|
16 |
18439678
|
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
|
17 |
18439678
|
We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue.
|
18 |
18439678
|
Sequence analysis showed that the aa sequence identities of porcine TLR7 with human, mouse and bovine TLR7 are 85, 78 and 90%, respectively, whereas porcine TLR8 aa sequence identities with human, mouse and bovine TLR8 are 73, 69 and 79%, respectively.
|
19 |
18439678
|
Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.
|
20 |
18439678
|
The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos-7 and 293T cells were analyzed using a NF-kappaB reporter assay.
|
21 |
18439678
|
Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.
|
22 |
18439678
|
We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum.
|
23 |
18439678
|
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
|
24 |
18439678
|
We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue.
|
25 |
18439678
|
Sequence analysis showed that the aa sequence identities of porcine TLR7 with human, mouse and bovine TLR7 are 85, 78 and 90%, respectively, whereas porcine TLR8 aa sequence identities with human, mouse and bovine TLR8 are 73, 69 and 79%, respectively.
|
26 |
18439678
|
Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.
|
27 |
18439678
|
The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos-7 and 293T cells were analyzed using a NF-kappaB reporter assay.
|
28 |
18439678
|
Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.
|
29 |
18439678
|
We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum.
|
30 |
18439678
|
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
|
31 |
18439678
|
We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue.
|
32 |
18439678
|
Sequence analysis showed that the aa sequence identities of porcine TLR7 with human, mouse and bovine TLR7 are 85, 78 and 90%, respectively, whereas porcine TLR8 aa sequence identities with human, mouse and bovine TLR8 are 73, 69 and 79%, respectively.
|
33 |
18439678
|
Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.
|
34 |
18439678
|
The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos-7 and 293T cells were analyzed using a NF-kappaB reporter assay.
|
35 |
18439678
|
Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.
|
36 |
18439678
|
We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum.
|
37 |
18439678
|
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
|
38 |
18439678
|
We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue.
|
39 |
18439678
|
Sequence analysis showed that the aa sequence identities of porcine TLR7 with human, mouse and bovine TLR7 are 85, 78 and 90%, respectively, whereas porcine TLR8 aa sequence identities with human, mouse and bovine TLR8 are 73, 69 and 79%, respectively.
|
40 |
18439678
|
Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.
|
41 |
18439678
|
The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos-7 and 293T cells were analyzed using a NF-kappaB reporter assay.
|
42 |
18439678
|
Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.
|
43 |
18439678
|
We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum.
|
44 |
18439678
|
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
|
45 |
18439678
|
We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue.
|
46 |
18439678
|
Sequence analysis showed that the aa sequence identities of porcine TLR7 with human, mouse and bovine TLR7 are 85, 78 and 90%, respectively, whereas porcine TLR8 aa sequence identities with human, mouse and bovine TLR8 are 73, 69 and 79%, respectively.
|
47 |
18439678
|
Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.
|
48 |
18439678
|
The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos-7 and 293T cells were analyzed using a NF-kappaB reporter assay.
|
49 |
18439678
|
Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.
|
50 |
18439678
|
We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum.
|
51 |
18439678
|
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
|
52 |
18439678
|
We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue.
|
53 |
18439678
|
Sequence analysis showed that the aa sequence identities of porcine TLR7 with human, mouse and bovine TLR7 are 85, 78 and 90%, respectively, whereas porcine TLR8 aa sequence identities with human, mouse and bovine TLR8 are 73, 69 and 79%, respectively.
|
54 |
18439678
|
Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.
|
55 |
18439678
|
The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos-7 and 293T cells were analyzed using a NF-kappaB reporter assay.
|
56 |
18439678
|
Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.
|
57 |
18439678
|
We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum.
|
58 |
18439678
|
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
|
59 |
18439678
|
We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue.
|
60 |
18439678
|
Sequence analysis showed that the aa sequence identities of porcine TLR7 with human, mouse and bovine TLR7 are 85, 78 and 90%, respectively, whereas porcine TLR8 aa sequence identities with human, mouse and bovine TLR8 are 73, 69 and 79%, respectively.
|
61 |
18439678
|
Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.
|
62 |
18439678
|
The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos-7 and 293T cells were analyzed using a NF-kappaB reporter assay.
|
63 |
18439678
|
Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.
|
64 |
18439678
|
We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum.
|
65 |
18474642
|
In the present study, we determined whether imiquimod and its related compound R848, which are TLR7 and/or TLR8 agonists, represent potential vaccine adjuvants when delivered topically, subcutaneously, or intramuscularly.
|
66 |
18789542
|
CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
|
67 |
18789542
|
Single-stranded viral RNA (ssRNA) was recently identified as the natural ligand for TLR7 and TLR8. ssRNA sequences from viruses, as well as their synthetic analogues stimulate innate immune responses in immune cells from humans and mice, but their immunostimulatory activity has not been investigated in ruminants.
|
68 |
18789542
|
In vitro incubation of bovine peripheral blood mononuclear cells (PBMCs) with ORN-induced production of IL-12, IFN-gamma and TNF-alpha.
|
69 |
18789542
|
Depletion of CD14+ cells from PBMC abrogated the IL-12 response and consequently the IFN-gamma response, suggesting that CD14+ cells are required for PBMC immune activation with ORN.
|
70 |
18789542
|
Consistent with these findings, the putative receptors for ORN (TLR7 and TLR8) were expressed at higher levels in the CD14+ fraction than the CD14- PBMC fraction.
|
71 |
18789542
|
CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
|
72 |
18789542
|
Single-stranded viral RNA (ssRNA) was recently identified as the natural ligand for TLR7 and TLR8. ssRNA sequences from viruses, as well as their synthetic analogues stimulate innate immune responses in immune cells from humans and mice, but their immunostimulatory activity has not been investigated in ruminants.
|
73 |
18789542
|
In vitro incubation of bovine peripheral blood mononuclear cells (PBMCs) with ORN-induced production of IL-12, IFN-gamma and TNF-alpha.
|
74 |
18789542
|
Depletion of CD14+ cells from PBMC abrogated the IL-12 response and consequently the IFN-gamma response, suggesting that CD14+ cells are required for PBMC immune activation with ORN.
|
75 |
18789542
|
Consistent with these findings, the putative receptors for ORN (TLR7 and TLR8) were expressed at higher levels in the CD14+ fraction than the CD14- PBMC fraction.
|
76 |
18789542
|
CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
|
77 |
18789542
|
Single-stranded viral RNA (ssRNA) was recently identified as the natural ligand for TLR7 and TLR8. ssRNA sequences from viruses, as well as their synthetic analogues stimulate innate immune responses in immune cells from humans and mice, but their immunostimulatory activity has not been investigated in ruminants.
|
78 |
18789542
|
In vitro incubation of bovine peripheral blood mononuclear cells (PBMCs) with ORN-induced production of IL-12, IFN-gamma and TNF-alpha.
|
79 |
18789542
|
Depletion of CD14+ cells from PBMC abrogated the IL-12 response and consequently the IFN-gamma response, suggesting that CD14+ cells are required for PBMC immune activation with ORN.
|
80 |
18789542
|
Consistent with these findings, the putative receptors for ORN (TLR7 and TLR8) were expressed at higher levels in the CD14+ fraction than the CD14- PBMC fraction.
|
81 |
18995910
|
Here we cloned and characterized bovine TLR8 (bTLR8) and found that it is highly responsive to two TLR7 ligands, imiquimod and gardiquimod, in transfected cell lines.
|
82 |
19330719
|
Intracellular TLRs, represented by TLRs 3, 7, 8 and 9, are specialized for the recognition of different types of microbe-derived nucleic acids.
|
83 |
19428918
|
Agonists for TLR7, TLR8, and TLR9 have been shown to enhance vaccine immunogenicity.
|
84 |
19449004
|
We observed expression of TLR7 and TLR8 in primary human AML cells and AML cell lines.
|
85 |
19525489
|
Innate immune stimulants may have applications as vaccine adjuvants as well as in the treatment of cancer and some viral diseases, and clinical studies have been performed using agonists of Toll-like receptors (TLRs) 7, 8, and 9.
|
86 |
20051250
|
Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells.
|
87 |
20051250
|
Sheep PBMC stimulated with either CpG (TLR9 agonist) or RNA oligoribonucleotides ([ORNs], TLR7/8 agonist) exhibited significant IL-12 production, but only CpG induced IFNalpha, IgM and proliferative responses.
|
88 |
20051250
|
In contrast, poly(I:C) (TLR3 agonist) and LPS (TLR4 agonist) did not induce any of these responses.
|
89 |
20051250
|
Sheep B cells constitutively expressed TLR7, TLR8 and TLR9 mRNA transcripts, suggesting a possible role of TLR cross-talk in the down-regulatory mechanisms.
|
90 |
20100933
|
We used multicolor flow cytometry and intracellular cytokine staining of myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) and found substantial decreases in older compared with young individuals in TNF-alpha, IL-6, and/or IL-12 (p40) production in mDCs and in TNF-alpha and IFN-alpha production in pDCs in response to TLR1/2, TLR2/6, TLR3, TLR5, and TLR8 engagement in mDCs and TLR7 and TLR9 in pDCs.
|
91 |
21403403
|
This endogenous immunostimulatory activity required nucleic acid and protein for its adjuvant effect and activated antigen-presenting cells through the RNA and DNA sensors TLR8 and TLR9.
|
92 |
21439318
|
Positive and double staining for CD11c and BDCA-2, pDC/IPC, DC-LAMP, DC-SIGN, TLR8 and Langerin have been observed revealing new mouse intestinal DC subsets.
|
93 |
21487111
|
TLR7 and TLR8 are intracellular sensors activated by single-stranded RNA species generated during viral infections.
|
94 |
21487111
|
Various synthetic small molecules can also activate TLR7 or TLR8 or both through an unknown mechanism.
|
95 |
21487111
|
Notably, direct interaction between small molecules and TLR7 or TLR8 has never been shown.
|
96 |
21487111
|
All fluorescent compounds induced the production of IFN-α, TNF-α, and IL-6 and the up-regulation of CD80 and CD86 by pDCs showing they retained TLR7-stimulating activity.
|
97 |
21487111
|
TLR7 and TLR8 are intracellular sensors activated by single-stranded RNA species generated during viral infections.
|
98 |
21487111
|
Various synthetic small molecules can also activate TLR7 or TLR8 or both through an unknown mechanism.
|
99 |
21487111
|
Notably, direct interaction between small molecules and TLR7 or TLR8 has never been shown.
|
100 |
21487111
|
All fluorescent compounds induced the production of IFN-α, TNF-α, and IL-6 and the up-regulation of CD80 and CD86 by pDCs showing they retained TLR7-stimulating activity.
|
101 |
21487111
|
TLR7 and TLR8 are intracellular sensors activated by single-stranded RNA species generated during viral infections.
|
102 |
21487111
|
Various synthetic small molecules can also activate TLR7 or TLR8 or both through an unknown mechanism.
|
103 |
21487111
|
Notably, direct interaction between small molecules and TLR7 or TLR8 has never been shown.
|
104 |
21487111
|
All fluorescent compounds induced the production of IFN-α, TNF-α, and IL-6 and the up-regulation of CD80 and CD86 by pDCs showing they retained TLR7-stimulating activity.
|
105 |
21533209
|
Most of the TLR agonists induced TNFα, IL-1β, IL-6, and IL-10 in cord blood.
|
106 |
21533209
|
The greatest TNFα responses were observed for TLR4, -5, and -8 agonists, the highest being the thiazoloquinoline CLO75 (TLR7/8) that also uniquely induced cord blood IFNγ production.
|
107 |
21533209
|
TLR8 agonists also induced the greatest production of the Th1-polarizing cytokines TNFα and IFNγ throughout the first year of life, although the relative responses to the single TLR8 agonist and the combined TLR7/8 agonist changed with age.
|
108 |
21533209
|
In contrast, IL-1β, IL-6, and IL-10 responses to most agonists were robust at birth and remained stable through 12 months of age.
|
109 |
21641953
|
They are also well suited to function as vaccine adjuvants. 3M imidazoquinoline (IRM) molecules were the first synthetic small molecules identified as TLR agonists and can affect their biological activities through TLR7, TLR8, or both.
|
110 |
21748646
|
Viral single-stranded (ss) RNA is the natural ligand for TLR7 and TLR8.
|
111 |
21748646
|
Synthetic ssRNA has been shown to act as a ligand for TLR7 and TLR8.
|
112 |
21748646
|
Viral single-stranded (ss) RNA is the natural ligand for TLR7 and TLR8.
|
113 |
21748646
|
Synthetic ssRNA has been shown to act as a ligand for TLR7 and TLR8.
|
114 |
21947541
|
TLR7 and TLR8 genetic variation may cause functional alterations that result in impaired responses to measles.
|
115 |
21947541
|
In a population of 12-month-old Australian infants, receptor protein expression was examined to assess the functionality of TLR7 and TLR8 polymorphisms, and the effects of these polymorphisms on cellular and antibody responses after the first measles vaccine dose were investigated.
|
116 |
21947541
|
None of the TLR7 or TLR8 polymorphisms studied were associated with measles-specific cytokine levels or with measles IgG levels.
|
117 |
21947541
|
In conclusion, we report gender-specific associations with TLR7 and TLR8 polymorphisms and TNF-α cellular responses to its ligand.
|
118 |
21947541
|
However, we found no evidence of any functional effects of TLR7 or TLR8 polymorphisms on receptor expression, measles-specific cellular responses or measles vaccine antibody responses.
|
119 |
21947541
|
TLR7 and TLR8 genetic variation may cause functional alterations that result in impaired responses to measles.
|
120 |
21947541
|
In a population of 12-month-old Australian infants, receptor protein expression was examined to assess the functionality of TLR7 and TLR8 polymorphisms, and the effects of these polymorphisms on cellular and antibody responses after the first measles vaccine dose were investigated.
|
121 |
21947541
|
None of the TLR7 or TLR8 polymorphisms studied were associated with measles-specific cytokine levels or with measles IgG levels.
|
122 |
21947541
|
In conclusion, we report gender-specific associations with TLR7 and TLR8 polymorphisms and TNF-α cellular responses to its ligand.
|
123 |
21947541
|
However, we found no evidence of any functional effects of TLR7 or TLR8 polymorphisms on receptor expression, measles-specific cellular responses or measles vaccine antibody responses.
|
124 |
21947541
|
TLR7 and TLR8 genetic variation may cause functional alterations that result in impaired responses to measles.
|
125 |
21947541
|
In a population of 12-month-old Australian infants, receptor protein expression was examined to assess the functionality of TLR7 and TLR8 polymorphisms, and the effects of these polymorphisms on cellular and antibody responses after the first measles vaccine dose were investigated.
|
126 |
21947541
|
None of the TLR7 or TLR8 polymorphisms studied were associated with measles-specific cytokine levels or with measles IgG levels.
|
127 |
21947541
|
In conclusion, we report gender-specific associations with TLR7 and TLR8 polymorphisms and TNF-α cellular responses to its ligand.
|
128 |
21947541
|
However, we found no evidence of any functional effects of TLR7 or TLR8 polymorphisms on receptor expression, measles-specific cellular responses or measles vaccine antibody responses.
|
129 |
21947541
|
TLR7 and TLR8 genetic variation may cause functional alterations that result in impaired responses to measles.
|
130 |
21947541
|
In a population of 12-month-old Australian infants, receptor protein expression was examined to assess the functionality of TLR7 and TLR8 polymorphisms, and the effects of these polymorphisms on cellular and antibody responses after the first measles vaccine dose were investigated.
|
131 |
21947541
|
None of the TLR7 or TLR8 polymorphisms studied were associated with measles-specific cytokine levels or with measles IgG levels.
|
132 |
21947541
|
In conclusion, we report gender-specific associations with TLR7 and TLR8 polymorphisms and TNF-α cellular responses to its ligand.
|
133 |
21947541
|
However, we found no evidence of any functional effects of TLR7 or TLR8 polymorphisms on receptor expression, measles-specific cellular responses or measles vaccine antibody responses.
|
134 |
21947541
|
TLR7 and TLR8 genetic variation may cause functional alterations that result in impaired responses to measles.
|
135 |
21947541
|
In a population of 12-month-old Australian infants, receptor protein expression was examined to assess the functionality of TLR7 and TLR8 polymorphisms, and the effects of these polymorphisms on cellular and antibody responses after the first measles vaccine dose were investigated.
|
136 |
21947541
|
None of the TLR7 or TLR8 polymorphisms studied were associated with measles-specific cytokine levels or with measles IgG levels.
|
137 |
21947541
|
In conclusion, we report gender-specific associations with TLR7 and TLR8 polymorphisms and TNF-α cellular responses to its ligand.
|
138 |
21947541
|
However, we found no evidence of any functional effects of TLR7 or TLR8 polymorphisms on receptor expression, measles-specific cellular responses or measles vaccine antibody responses.
|
139 |
22239408
|
We describe the syntheses and evaluation of TLR7 and TLR8 modulatory activities of dimeric constructs of imidazoquinoline linked at the C2, C4, C8, and N(1)-aryl positions.
|
140 |
22239408
|
Dimers linked at C2 position showed antagonistic activities at TLR7 and TLR8; the C2 dimer with a propylene spacer was maximally antagonistic at both TLR7 and TLR8.
|
141 |
22239408
|
We describe the syntheses and evaluation of TLR7 and TLR8 modulatory activities of dimeric constructs of imidazoquinoline linked at the C2, C4, C8, and N(1)-aryl positions.
|
142 |
22239408
|
Dimers linked at C2 position showed antagonistic activities at TLR7 and TLR8; the C2 dimer with a propylene spacer was maximally antagonistic at both TLR7 and TLR8.
|
143 |
22521247
|
Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.
|
144 |
22617845
|
HLA class II genotype and suppression of transcript expression for TLR2, TLR4 and TLR8 in the nonresponder group may help explain the lack of vaccine response in this study group.
|
145 |
22952720
|
We synthesized a dendrimeric molecule bearing six units of a potent TLR7/TLR8 dual-agonistic imidazoquinoline to explore if multimerization of TLR7/8 would result in altered activity profiles.
|
146 |
22952720
|
A complete loss of TLR8-stimulatory activity with selective retention of the TLR7-agonistic activity was observed in the dendrimer.
|
147 |
22952720
|
This was reflected by a complete absence of TLR8-driven proinflammatory cytokine and interferon (IFN)-γ induction in human PBMCs, with preservation of TLR7-driven IFN-α induction.
|
148 |
22952720
|
We synthesized a dendrimeric molecule bearing six units of a potent TLR7/TLR8 dual-agonistic imidazoquinoline to explore if multimerization of TLR7/8 would result in altered activity profiles.
|
149 |
22952720
|
A complete loss of TLR8-stimulatory activity with selective retention of the TLR7-agonistic activity was observed in the dendrimer.
|
150 |
22952720
|
This was reflected by a complete absence of TLR8-driven proinflammatory cytokine and interferon (IFN)-γ induction in human PBMCs, with preservation of TLR7-driven IFN-α induction.
|
151 |
22952720
|
We synthesized a dendrimeric molecule bearing six units of a potent TLR7/TLR8 dual-agonistic imidazoquinoline to explore if multimerization of TLR7/8 would result in altered activity profiles.
|
152 |
22952720
|
A complete loss of TLR8-stimulatory activity with selective retention of the TLR7-agonistic activity was observed in the dendrimer.
|
153 |
22952720
|
This was reflected by a complete absence of TLR8-driven proinflammatory cytokine and interferon (IFN)-γ induction in human PBMCs, with preservation of TLR7-driven IFN-α induction.
|
154 |
23850441
|
Activations of endosomal TLRs include TLR3, TLR7/8, and TLR9 stimulates the production of cytokines, such as type I interferons (IFNs), and therefore involves in virus-host interactions.
|
155 |
23850441
|
Our results showed that EIAVFDDV13 dramatically up-regulated the expression of TLR3 and IFNβ and less robustly up-regulated the expression of TRL9 and IFNα1, whereas EIAVFDDV3-8 induced significantly lower expression of type I IFN mRNA and protein and more strongly down-regulated the expression of TLR7 and TLR8.
|
156 |
24012797
|
TLRs 3, 4, 7, 8 and 9 are all validated targets for cancer and a number of companies are developing agonists and vaccine adjuvants.
|
157 |
24853609
|
MPL® (a TLR4 agonist) and the CpG oligodeoxynucleotide of 1018 ISS, a TLR9 agonist, show strong immunogenicity effects that make them appropriate adjuvants for allergy vaccines.
|
158 |
24853609
|
In addition, intranasal administration of AZD8848 (a TLR7 agonist) and VTX-1463 (a TLR8 agonist) as stand-alone therapeutics have revealed efficacy in the relief of the symptoms of AR patients.
|
159 |
25102141
|
Comprehensive structure-activity relationships in ring-contracted 1-alkyl-1H-benzimidazol-2-amines were undertaken, and the best-in-class compound, 4-methyl-1-pentyl-1H-benzo[d]imidazol-2-amine, was found to be a pure TLR8 agonist, evoking strong proinflammatory cytokine and Type II interferon responses in human PBMCs, with no attendant CD69 upregulation in natural lymphocytic subsets.
|
160 |
25131730
|
TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
|
161 |
25131730
|
Toll-like receptors 7 (TLR7) and 8 (TLR8) recognize viral single-stranded RNA and small molecular weight agonists to activate anti-viral immune responses.
|
162 |
25131730
|
TLR7 and TLR8 have been reported to be absent and pseudogenized, respectively, in rabbit (Oryctolagus cuniculus).
|
163 |
25131730
|
TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
|
164 |
25131730
|
Toll-like receptors 7 (TLR7) and 8 (TLR8) recognize viral single-stranded RNA and small molecular weight agonists to activate anti-viral immune responses.
|
165 |
25131730
|
TLR7 and TLR8 have been reported to be absent and pseudogenized, respectively, in rabbit (Oryctolagus cuniculus).
|
166 |
25131730
|
TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
|
167 |
25131730
|
Toll-like receptors 7 (TLR7) and 8 (TLR8) recognize viral single-stranded RNA and small molecular weight agonists to activate anti-viral immune responses.
|
168 |
25131730
|
TLR7 and TLR8 have been reported to be absent and pseudogenized, respectively, in rabbit (Oryctolagus cuniculus).
|
169 |
25192394
|
Previous SAR investigations in several scaffolds of small molecule TLR7/8 activators pointed to the strict dependence of the selectivity for TLR7 vis-à-vis TLR8 on the electronic configurations of the heterocyclic systems, which we sought to examine quantitatively with the goal of developing "heuristics" to define structural requisites governing activity at TLR7 and/or TLR8.
|
170 |
25192394
|
Density functional theory based quantum chemical calculations on these compounds followed by linear discriminant analyses permitted the classification of inactive, TLR8-active, and TLR7/8 dual-active compounds, confirming the critical role of partial charges in determining biological activity.
|
171 |
25192394
|
Previous SAR investigations in several scaffolds of small molecule TLR7/8 activators pointed to the strict dependence of the selectivity for TLR7 vis-à-vis TLR8 on the electronic configurations of the heterocyclic systems, which we sought to examine quantitatively with the goal of developing "heuristics" to define structural requisites governing activity at TLR7 and/or TLR8.
|
172 |
25192394
|
Density functional theory based quantum chemical calculations on these compounds followed by linear discriminant analyses permitted the classification of inactive, TLR8-active, and TLR7/8 dual-active compounds, confirming the critical role of partial charges in determining biological activity.
|
173 |
25229618
|
A humanized TLR7/TLR8 transgenic mouse line was engineered for studies using TLR7/8 ligands as vaccine adjuvants.
|
174 |
25229618
|
Illness may be caused by constitutive activation of human TLR7 or TLR8 in the bacterial artificial chromosome positive mice as increased TLR7 and TLR8 expression or activation has previously been implicated in autoimmune disease.
|
175 |
25229618
|
A humanized TLR7/TLR8 transgenic mouse line was engineered for studies using TLR7/8 ligands as vaccine adjuvants.
|
176 |
25229618
|
Illness may be caused by constitutive activation of human TLR7 or TLR8 in the bacterial artificial chromosome positive mice as increased TLR7 and TLR8 expression or activation has previously been implicated in autoimmune disease.
|
177 |
25698055
|
In vitro evaluation of the piperidinyl-substituted oxoadenines 3a-g in human TLR7- or TLR8-transfected HEK293 cells and in human PBMCs indicated that TLR7/8 selectivity/potency and cytokine induction can be modulated by varying the length of the alkyl linker.
|
178 |
26054788
|
Despite this limitation, increased IFN-1, TLR-7 and IgM gene expression was detected by qRT-PCR in kidney of vaccinated fish when a 10 μg dose of the oral pIRF1A-G vaccine was administered.
|
179 |
26054788
|
In contrast, significant Mx-1, Vig-1, Vig-2, TLR-3 and TLR-8 gene expression was only detected when higher doses of pIRF1A-G (50 and 100 μg) were orally administered.
|
180 |
26054788
|
The pIRF1A-G vaccine also induced the expression of several markers of the adaptive immune response (CD4, CD8, IgM and IgT) in kidney and spleen of immunized fish in a dose-dependent manner.
|
181 |
26182986
|
We isolated RNA from peripheral blood mononuclear cells and, with PCR, detected transcripts for TLRs 2, 3, 4, 5, 6, 7, 8, 9, 10 and 13.
|
182 |
26182986
|
Stimulation of the mononuclear cells with agonists to these TLRs increased the expression of downstream TLR signaling products (IL1α, IL6, IL12A and IFNβ).
|